Market Herald logo

Subscribe

Be the first with the news that moves the market

An investor’s guide to the opportunities within the cannabis market. Click here to access the report.

In this maiden report, The Market Herald Thematica takes a deep dive into the world of alternative medicines, including cannabis and psychedelics.

Mixing compelling research with exclusive data insights, the report examines the future of cannabis in Australia, the current market conditions, as well as the forces affecting ASX-listed healthcare stocks.

Featured throughout are also profiles of the companies operating in the cannabis and psychadelics space in Australia, along with case studies of the people who want to access alternative medicines.

Whether a new or existing investor, cannabis and other frontier treatments are shaping up to be a key part of the future of healthcare.

Access The Market Herald Thematica’s Cannabis Report here.

More From The Market Herald

" Crowd Media (ASX:CM8): Talking Head and the new age of consumer interaction

ASX-listed Crowd Media (ASX:CM8) is no stranger to artificial intelligence (AI)-based technology, and the company is…
MoneyMe (ASX:MME) - CEO & Managing Director, Clayton Howes

" MoneyMe (ASX:MME): Embracing new tech for scalable lending solutions

MoneyMe (ASX:MME) is embracing new technology, such as AI, to generate better outcomes for itself and…
The Market Herald Video

" Cavalier Resources (ASX:CVR) hits the ground running with successful $5m IPO

WA-based gold and nickel explorer Cavalier Resources (ASX:CVR) has officially joined the ranks of the ASX…